Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Personalized Medicine and its Impact in the Clinic

Arijit Chakravarty's Biography



Arijit Chakravarty, Director, Takeda Pharmaceuticals Co Ltd

I am a 'wet/dry' biologist in the Translational Oncology space. Over the course of my career, I have been a group leader for teams of cell biology, in vivo pharmacology, translational and mathematical modeling scientists. As a discovery project leader for seven molecules in early clinical development, I was responsible for the translational portion of the preclinical package.

My team is responsible for PK/PD modeling support to expedite drug discovery and development. A particular focus of our effort is in developing predictive ADME models, and in leveraging PK/PD/E modeling to facilitate the early-stage discovery process.

Arijit Chakravarty Image

Predicting the Predictiveness: Preclinical-to-clinical Bridging of Personalized Therapies using Translational Modeling

Wednesday, 7 October 2015 at 14:00

Add to Calendar ▼2015-10-07 14:00:002015-10-07 15:00:00Europe/LondonPredicting the Predictiveness: Preclinical-to-clinical Bridging of Personalized Therapies using Translational ModelingPersonalized Medicine and its Impact in the Clinic in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.com


Add to Calendar ▼2015-10-07 00:00:002015-10-08 00:00:00Europe/LondonPersonalized Medicine and its Impact in the ClinicPersonalized Medicine and its Impact in the Clinic in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.com